Imperva Inc (NYSE:IMPV)‘s stock had its “neutral” rating reiterated by stock analysts at Piper Jaffray Companies in a research note issued on Friday, Marketbeat reports. They currently have a $58.00 target price on the software maker’s stock. Piper Jaffray Companies’ price objective points to a potential upside of 33.03% from the stock’s previous close.

IMPV has been the subject of several other research reports. Zacks Investment Research upgraded shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $52.00 target price for the company in a research note on Wednesday, August 2nd. Evercore ISI set a $56.00 target price on shares of Imperva and gave the company a “buy” rating in a research note on Friday, July 28th. BidaskClub upgraded shares of Imperva from a “sell” rating to a “hold” rating in a research note on Tuesday, August 22nd. Wells Fargo & Company cut shares of Imperva from an “outperform” rating to a “market perform” rating in a research note on Monday, October 9th. Finally, Monness Crespi & Hardt increased their target price on shares of Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. Imperva currently has an average rating of “Hold” and an average target price of $51.34.

Imperva (NYSE:IMPV) traded down 5.28% on Friday, hitting $41.30. The company had a trading volume of 807,821 shares. Imperva has a 12-month low of $34.40 and a 12-month high of $52.40. The firm’s 50 day moving average price is $44.07 and its 200 day moving average price is $45.89. The stock’s market cap is $1.40 billion.

Imperva (NYSE:IMPV) last released its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.15). Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. During the same quarter in the previous year, the business posted ($0.23) EPS. The firm’s quarterly revenue was up 28.6% on a year-over-year basis. Equities analysts predict that Imperva will post $0.81 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Imperva Inc (IMPV) Given Neutral Rating at Piper Jaffray Companies” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another website, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/14/piper-jaffray-companies-reiterates-buy-rating-for-imperva-inc-impv-2.html.

In other news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction that occurred on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now owns 99,598 shares in the company, valued at $4,341,476.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.20% of the stock is owned by company insiders.

Large investors have recently bought and sold shares of the company. Ameritas Investment Partners Inc. bought a new position in shares of Imperva in the first quarter valued at approximately $102,000. KCG Holdings Inc. bought a new position in shares of Imperva in the first quarter valued at approximately $201,000. Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Imperva by 26.2% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after acquiring an additional 866 shares during the last quarter. Amalgamated Bank bought a new position in shares of Imperva in the second quarter valued at approximately $206,000. Finally, US Bancorp DE raised its stake in shares of Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock valued at $221,000 after acquiring an additional 3,163 shares during the last quarter. Institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.